Track: Cardiovascular Pharmacology and Toxicology

The
"Cardiovascular Pharmacology and Toxicology" session will
explore the latest advancements in the pharmacological management of
cardiovascular diseases, focusing on how drugs influence heart health and the
potential risks associated with cardiovascular medications. It will cover the
mechanisms of action of emerging drug therapies, including novel classes of
antihypertensives, anticoagulants, and lipid-lowering agents, and their impact
on patient outcomes. By examining both the benefits and risks of
cardiovascular pharmacology, this session will provide participants with
valuable insights into optimizing drug therapies and minimizing toxicity in
cardiovascular care.
Mechanisms of
Action of Cardiovascular Drugs: Delve into the mechanisms through which
cardiovascular drugs exert their effects, including how they impact cardiac
contractility, heart rate, blood pressure, and vascular tone. Learn how these
drugs help modulate heart function, reduce symptoms, and improve patient
outcomes in various cardiovascular diseases.
Drug Therapy
in Heart Failure: Explore the pharmacological management of heart failure,
including the use of angiotensin-converting enzyme (ACE) inhibitors,
angiotensin receptor blockers (ARBs), beta-blockers, diuretics, aldosterone
antagonists, and inotropes. Understand how combination therapies are used to
optimize treatment and manage both acute and chronic heart failure.
Antithrombotic
Therapy in Cardiovascular Disease: Gain insights into the use of antiplatelet
agents (e.g., aspirin, clopidogrel) and anticoagulants (e.g., warfarin, direct
oral anticoagulants (DOACs)) in preventing thromboembolic events, such as
stroke, myocardial infarction, and deep vein thrombosis.
Pharmacogenomics
in Cardiovascular Therapy: Explore the role of pharmacogenomics in
cardiovascular therapy, focusing on how genetic variations influence drug
responses in patients with cardiovascular diseases.
Cardiovascular
Toxicology: Examine the potential toxic effects of certain drugs, environmental
toxins, and substances on the cardiovascular system. Discuss the mechanisms
behind drug-induced cardiotoxicity, including damage to the myocardium,
vasculature, and conduction system.
Adverse Drug
Reactions and Drug Interactions: Learn about the common adverse drug reactions
(ADRs) and drug interactions that can occur in patients receiving
cardiovascular medications. Understand how certain medications may interact
with each other or with food and herbal supplements, leading to reduced
efficacy or harmful effects on heart health.
Innovations in
Cardiovascular Drug Development: Explore the latest advancements in
cardiovascular drug development, including new classes of medications for heart
failure, hypertension, and hyperlipidemia, as well as novel therapeutic
approaches such as gene therapy and regenerative medicine.
Toxicology of
Environmental Factors on the Cardiovascular System: Investigate how exposure to
environmental factors such as air pollution, heavy metals, and endocrine
disruptors can contribute to cardiovascular disease. Learn about the
toxicological effects of these agents on cardiovascular health and the
strategies used to mitigate these risks.
Scientific Highlights
- Cardiovascular Diseases and Disorders
- Interventional Cardiology
- Cardiac Surgery
- Cardiac Anesthesia and Critical Care
- Valvular Heart Disease
- Pediatric and Congenital Heart Disease
- Hypertension and Stroke
- Electrophysiology and Arrhythmias
- Cardiac Imaging and Nuclear Cardiology
- Cardio-Oncology
- Heart Failure and Cardiomyopathies
- Vascular and Endovascular Surgery
- Insights in Cardiopulmonology and Neurocardiology
- Cardiovascular Endocrinology and Metabolism
- Cardiac Nursing and Women’s Heart Health
- Cardiovascular Pharmacology and Toxicology
- Preventive Cardiology and Cardiac Rehabilitation
- Emerging Frontiers in Cardiology